Cargando…

Differential expression of HAVCR2 gene in pan-cancer: A potential biomarker for survival and immunotherapy

T-cell immunoglobulin mucin 3 (TIM-3) has emerged as a promising immune checkpoint target in cancer therapy. However, the profile of the hepatitis A virus cellular receptor 2 (HAVCR2) gene, encoding TIM-3 expression, is still obscure, along with its role in cancer immunity and prognosis. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hetong, Yang, Dinglong, Hao, Min, Liu, Hongqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445440/
https://www.ncbi.nlm.nih.gov/pubmed/36081997
http://dx.doi.org/10.3389/fgene.2022.972664